44 results on '"Mouillac, Bernard"'
Search Results
2. The ligand-bound state of a G protein-coupled receptor stabilizes the interaction of functional cholesterol molecules
3. Chapter Seven - Misfolding of vasopressin receptors: biased agonist pharmacochaperones as potential therapeutics
4. Design, synthesis and biological studies of a library of NK1-Receptor Ligands Based on a 5-arylthiosubstituted 2-amino-4,6-diaryl-3-cyano-4H-pyran core: Switch from antagonist to agonist effect by chemical modification
5. Vasopressin receptors and pharmacological chaperones: From functional rescue to promising therapeutic strategies
6. Chapter Three - Structures of the arginine-vasopressin and oxytocin receptor signaling complexes
7. Heterodimerization with Its Splice Variant Blocks the Ghrelin Receptor 1a in a Non-signaling Conformation: A STUDY WITH A PURIFIED HETERODIMER ASSEMBLED INTO LIPID DISCS*
8. Expression, purification and NMR characterization of the cyclic recombinant form of the third intracellular loop of the vasopressin type 2 receptor
9. New advances in production and functional folding of G-protein-coupled receptors
10. Leukotriene BLT2 Receptor Monomers Activate the Gi2 GTP-binding Protein More Efficiently than Dimers
11. Structure of the Third Intracellular Loop of the Vasopressin V2 Receptor and Conformational Changes upon Binding to gC1qR
12. The multifunctional protein GC1q-R interacts specifically with the i3 loop arginine cluster of the vasopressin V 2 receptor
13. Peptide and non-peptide agonists and antagonists for the vasopressin and oxytocin V1a, V1b, V2 and OT receptors: research tools and potential therapeutic agents
14. Crosslinking Photosensitized by a Ruthenium Chelate as a Tool for Labeling and Topographical Studies of G-Protein-Coupled Receptors
15. Identification of the Binding Sites of the SR49059 Nonpeptide Antagonist into the V1a Vasopressin Receptor Using Sulfydryl-reactive Ligands and Cysteine Mutants as Chemical Sensors
16. Chapter 13 Expression of human vasopressin and oxytocin receptors in Escherichia coli
17. Direct Identification of Human Oxytocin Receptor-binding Domains Using a Photoactivatable Cyclic Peptide Antagonist: COMPARISON WITH THE HUMAN V1a VASOPRESSIN RECEPTOR
18. Docking of Linear Peptide Antagonists into the Human V1a Vasopressin Receptor: IDENTIFICATION OF BINDING DOMAINS BY PHOTOAFFINITY LABELING
19. Crystal structure and functional domains of the Mambaquaretin-1, a vasopressin type 2 receptor peptide inhibitor for kidney cysts treatment
20. V-1A Vasopressin Receptor
21. OT Oxytocin Receptor
22. V-1B Vasopressin Receptor
23. V-2 Vasopressin Receptor
24. Vasopressin-Oxytocin Receptors
25. Pharmacological characterization of inositol 1,4,5,-trisphosphate binding sites: relation to Ca 2+ release
26. Desensitization, phosphorylation and palmitoylation of the human dopamine D 1 receptor
27. Properties of membranous phospholipase C from WRK 1 cell: Sensitivity to guanylnucleotides and bacterial toxins
28. Positive feedback regulation of phospholiphase C by vasopressin-induced calcium mobilization in WRK1 cells
29. Mechanisms of phospholipase C activation: a comparison with the adenylate cyclase system
30. 3D MODELS OF HORMONE RECEPTORS : EXPERIMENTAL VALIDATION
31. Towards understanding the role of the first extracellular loop for the binding of peptide hormones to G-protein coupled receptors
32. Palmitoylated Cysteine 341 Modulates Phosphorylation of the β2-Adrenergic Receptor by the cAMP-dependent Protein Kinase
33. Identification of Residues Responsible for the Selective Binding of Peptide Antagonists and Agonists in the V2 Vasopressin Receptor
34. The Binding Site of Neuropeptide Vasopressin V1a Receptor: EVIDENCE FOR A MAJOR LOCALIZATION WITHIN TRANSMEMBRANE REGIONS
35. Mapping Peptide-binding Domains of the Human V1a Vasopressin Receptor with a Photoactivatable Linear Peptide Antagonist
36. The D136A mutation of the V 2 vasopressin receptor induces a constitutive activity which permits discrimination between antagonists with partial agonist and inverse agonist activities
37. Two aromatic residues regulate the response of the human oxytocin receptor to the partial agonist arginine vasopressin
38. Properties of a new radioiodinated antagonist for human vasopressin V 2 and V 1a receptors
39. Influence of receptor density on the patterns of β 2-adrenoceptor desensitization
40. Transient inositol (1,4,5) trisphosphate accumulation under vasopressin stimulation in WRK 1 cells: correlation with intracellular calcium mobilization
41. [24] Dynamic palmitoylation of G-protein-coupled receptors in eukaryotic cells
42. Activation of membrane phospholipase C by vasopressin: A requirement for guanyl nucleotides
43. Activation of polyphosphoinositide phospholipase C by fluoride in WRK1 cell membranes
44. Investigation of receptor-ligand interactions of the Oxytocin/Vasopressin receptor family by molecular modeling and site directed mutagenesis studies
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.